Keybank National Association OH Has $33.81 Million Holdings in CME Group Inc. (NASDAQ:CME)

Keybank National Association OH decreased its position in CME Group Inc. (NASDAQ:CME) by 0.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 145,570 shares of the financial services provider’s stock after selling 1,190 shares during the quarter. Keybank National Association OH’s holdings in CME Group were worth $33,806,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Meyer Handelman Co. acquired a new stake in CME Group in the 4th quarter valued at approximately $6,144,000. Spire Wealth Management lifted its position in shares of CME Group by 37.4% in the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock worth $307,000 after purchasing an additional 359 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc boosted its holdings in CME Group by 19.3% during the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after purchasing an additional 52,862 shares during the last quarter. Bank of Montreal Can grew its position in CME Group by 41.8% in the third quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after purchasing an additional 303,169 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in CME Group by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after buying an additional 142,692 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Royal Bank of Canada lifted their target price on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. Morgan Stanley upped their price objective on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 19th. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $255.00 to $250.00 in a research report on Monday, January 6th. Oppenheimer upped their target price on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Finally, Piper Sandler lifted their price target on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus target price of $236.13.

Insider Buying and Selling at CME Group

In other news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 3,984 shares of the company’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now owns 27,046 shares in the company, valued at approximately $6,774,211.62. This represents a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 17,076 shares of company stock valued at $4,271,496 over the last three months. 0.30% of the stock is currently owned by insiders.

CME Group Stock Down 1.9 %

CME opened at $251.98 on Wednesday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $258.78. The firm has a market capitalization of $90.80 billion, a P/E ratio of 26.06, a PEG ratio of 6.76 and a beta of 0.57. The company’s 50-day moving average is $239.05 and its 200 day moving average is $229.89. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be issued a $1.25 dividend. The ex-dividend date is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.98%. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is 51.71%.

CME Group announced that its Board of Directors has initiated a stock buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.